These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11044426)

  • 21. Fontan fenestration closure has no acute effect on exercise capacity but improves ventilatory response to exercise.
    Meadows J; Lang P; Marx G; Rhodes J
    J Am Coll Cardiol; 2008 Jul; 52(2):108-13. PubMed ID: 18598888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Closure of extrocardiac Fontan fenestration by using the Amplatzer duct occluder].
    Boudjemline Y; Bonnet D; Sidi D; Agnoletti G
    Arch Mal Coeur Vaiss; 2005 May; 98(5):449-54. PubMed ID: 15966592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late surgical fenestration for complications after the Fontan operation.
    Rychik J; Rome JJ; Jacobs ML
    Circulation; 1997 Jul; 96(1):33-6. PubMed ID: 9236413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of institutional criteria for transcatheter device closure of Fontan fenestration - Midterm outcomes.
    Thatte N; Dimas V; Nugent A; Zellers T; Forbess J; Zabala L; Zhang S; Veeram Reddy SR
    Ann Pediatr Cardiol; 2020; 13(4):327-333. PubMed ID: 33311921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac catheterization and test occlusion of the interatrial communication after the fenestrated Fontan operation.
    Bridges ND; Lock JE; Mayer JE; Burnett J; Castaneda AR
    J Am Coll Cardiol; 1995 Jun; 25(7):1712-7. PubMed ID: 7759728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parameters associated with perioperative baffle fenestration closure in the Fontan operation.
    Casta A; Gruber EM; Laussen PC; McGowan FX; Odegard KC; Zurakowski D; Hansen DD
    J Cardiothorac Vasc Anesth; 2000 Oct; 14(5):553-6. PubMed ID: 11052437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haemodynamic characteristics before and after the onset of protein losing enteropathy in patients after the Fontan operation.
    Ohuchi H; Yasuda K; Miyazaki A; Kitano M; Sakaguchi H; Yazaki S; Tsuda E; Yamada O
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):e49-57. PubMed ID: 23396878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Failed transcatheter creation of fenestration in a Fontan patient with original fenestration closed by AngelWings septal occluder: a case report].
    Ohno A; Hirotaka I; Kobayashi T; Asano H; Kyo S; Senzaki H
    J Cardiol; 2007 Oct; 50(4):271-5. PubMed ID: 17987844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fontan fenestration closure and event-free survival.
    Imielski BR; Woods RK; Mussatto KA; Cao Y; Simpson PM; Tweddell JS
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):183-7. PubMed ID: 23062415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients.
    Bartz PJ; Driscoll DJ; Dearani JA; Puga FJ; Danielson GK; O'Leary PW; Earing MG; Warnes CA; Hodge DO; Cetta F
    J Am Coll Cardiol; 2006 Dec; 48(11):2301-5. PubMed ID: 17161263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Fontan Conversion for Patients Without Late Fontan Complications be Justified?
    Higashida A; Hoashi T; Kagisaki K; Shimada M; Ohuchi H; Shiraishi I; Ichikawa H
    Ann Thorac Surg; 2017 Jun; 103(6):1963-1968. PubMed ID: 28242080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of the Fontan operation.
    Driscoll DJ
    Pediatr Cardiol; 2007; 28(6):438-42. PubMed ID: 17768650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Closure of Fontan fenestration with the use of covered stents: short- and mid-term results in a cohort of 50 patients.
    Malekzadeh-Milani S; Ladouceur M; Bajolle F; Bonnet D; Boudjemline Y
    Cardiol Young; 2015 Jun; 25(5):868-73. PubMed ID: 24914999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Optimal Fenestration Size on Outcomes of High-Risk Fontan Patients.
    Miwa K; Iwai S; Kanaya T; Kawai S
    World J Pediatr Congenit Heart Surg; 2024 Jan; 15(1):65-73. PubMed ID: 37899580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fenestration in the Fontan circulation as a strategy for chronic cardioprotection.
    Saiki H; Kuwata S; Iwamoto Y; Ishido H; Taketazu M; Masutani S; Nishida T; Senzaki H
    Heart; 2019 Aug; 105(16):1266-1272. PubMed ID: 30826770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of 200 patients after an extracardiac Fontan procedure.
    Kim SJ; Kim WH; Lim HG; Lee JY
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):108-16. PubMed ID: 18603062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic antifibrinolytics are not associated with an increased incidence of baffle fenestration closure after the modified Fontan procedure.
    Gruber EM; Shukla AC; Reid RW; Hickey PR; Hansen DD
    J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):257-9. PubMed ID: 10890476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate results of the extracardiac Fontan procedure.
    Laschinger JC; Redmond JM; Cameron DE; Kan JS; Ringel RE
    Ann Thorac Surg; 1996 Nov; 62(5):1261-7; discussion 1266-7. PubMed ID: 8893555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Fontan conversion for failing Fontan circulation: mid-term results.
    Park HK; Shin HJ; Park YH
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):14-7. PubMed ID: 27001674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter fenestration dilation and/or creation in postoperative Fontan patients.
    Kreutzer J; Lock JE; Jonas RA; Keane JF
    Am J Cardiol; 1997 Jan; 79(2):228-32. PubMed ID: 9193035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.